The Impact of Antimicrobial Stewardship and Accurate Susceptibility Results on Patients with Sepsis

New Antibiotics and Diagnostics for Improved Outcomes

Sepsis is a leading cause of morbidity and mortality, resulting in over 250,000 deaths in the U.S. annually. Current rapid diagnostics don’t provide the information needed for accurate diagnosis and prognosis of acute infections and sepsis. Clinical decisions—including timing, dosage therapy, and level-of-care determinations—rely on understanding the etiology and the implications of the patient’s clinical presentation.

Early treatment with appropriate antibiotics has been shown to reduce morbidity and mortality in cases of bacterial sepsis. However, an estimated 20% of hospitalized patients treated with parenteral antibiotics experience an adverse drug event, and over two million people are diagnosed with antibiotic-resistant infections each year. In this webinar, you’ll learn about new antibiotics and diagnostic testing that can provide accurate minimum inhibitory concentration (MIC) antibiotic susceptibility results to help determine more effective treatment and improve outcomes for critically ill patients.

Learning Objectives

This webinar will help you:

• Evaluate testing options for the rapid identification of sepsis and antibiotic-resistant infections
• Demonstrate how therapeutics based on new diagnostic methods can help reduce cost and risk
• Clarify the impact of effective therapy on survival rates of patients with acute infections and sepsis
• Discuss effective stewardship practices on mortality and how accurate laboratory data can guide appropriate decision-making

Watch on Demand       Download Slides (PDF, 1.3MB)

Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.

Nathan Ledeboer, PhD, Professor of Pathology & Laboratory Medicine and Chief of Clinical Pathology at the Medical College of Wisconsin and Associate Chief Medical Officer for Laboratory Services at Froedtert Health

As the director of medical and technical activities for laboratory services at the Medical College of Wisconsin and Froedtert Health, Dr. Ledeboer oversees new assay development and implementation, approves all testing performed in these laboratories, and consults with physician colleagues regarding diagnostic test selection and result interpretation.